Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Suprapubic catheter placement improves antimicrobial stewardship among Veterans Affairs nursing care facility residents.

Buehrle DJ, Clancy CJ, Decker BK.

Am J Infect Control. 2020 Feb 13. pii: S0196-6553(20)30014-6. doi: 10.1016/j.ajic.2020.01.005. [Epub ahead of print]

PMID:
32063396
2.

Clinical Presentation of Community-Acquired Legionella Pneumonia Identified by Universal Testing in an Endemic Area.

Puri S, Boudreaux-Kelly M, Walker JD, Clancy CJ, Decker BK.

Int J Environ Res Public Health. 2020 Jan 15;17(2). pii: E533. doi: 10.3390/ijerph17020533.

3.

Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime-avibactam resistance emerged are not hypermutators.

Squires KM, Nguyen MH, Shields RK, Clancy CJ.

Diagn Microbiol Infect Dis. 2020 Mar;96(3):114954. doi: 10.1016/j.diagmicrobio.2019.114954. Epub 2019 Nov 23.

PMID:
31864758
4.

Sustained Reductions in Overall and Unnecessary Antibiotic Prescribing at Primary Care Clinics in a Veterans Affairs Healthcare System following a Multi-faceted Stewardship Intervention.

Buehrle DJ, Shively NR, Wagener MM, Clancy CJ, Decker BK.

Clin Infect Dis. 2019 Dec 9. pii: ciz1180. doi: 10.1093/cid/ciz1180. [Epub ahead of print]

PMID:
31813965
5.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
6.

Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Wu X, Venkataramanan R, Rivosecchi RM, Tang C, Marini RV, Shields RK, Clancy CJ, Nguyen MH.

Antimicrob Agents Chemother. 2020 Jan 27;64(2). pii: e01728-19. doi: 10.1128/AAC.01728-19. Print 2020 Jan 27.

PMID:
31767725
7.

Early experience with meropenem-vaborbactam for treatment of carbapenem-resistant Enterobacteriaceae infections.

Shields RK, McCreary EK, Marini RV, Kline EG, Jones CE, Hao B, Chen L, Kreiswirth BN, Doi Y, Clancy CJ, Nguyen MH.

Clin Infect Dis. 2019 Nov 18. pii: ciz1131. doi: 10.1093/cid/ciz1131. [Epub ahead of print]

PMID:
31738396
8.

Improved Antibiotic Prescribing within a Veterans Affairs Primary Care System through a Multifaceted Intervention Centered on Peer Comparison of Overall Antibiotic Prescribing Rates.

Shively NR, Buehrle DJ, Wagener MM, Clancy CJ, Decker BK.

Antimicrob Agents Chemother. 2019 Dec 20;64(1). pii: e00928-19. doi: 10.1128/AAC.00928-19. Print 2019 Dec 20.

PMID:
31685466
9.

Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data.

Clancy CJ, Potoski BA, Buehrle D, Nguyen MH.

Open Forum Infect Dis. 2019 Jul 28;6(8):ofz344. doi: 10.1093/ofid/ofz344. eCollection 2019 Aug.

10.

Estimating the size of the United States market for new antibiotics with activity against carbapenem-resistant Enterobacteriaceae.

Clancy CJ, Nguyen MH.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01733-19. doi: 10.1128/AAC.01733-19. [Epub ahead of print]

PMID:
31591123
11.

Rapid diagnosis of invasive candidiasis: ready for prime-time?

Clancy CJ, Nguyen MH.

Curr Opin Infect Dis. 2019 Dec;32(6):546-552. doi: 10.1097/QCO.0000000000000594.

PMID:
31567567
12.

Pharmacokinetics and Dialytic Clearance of Isavuconazole During In Vitro and In Vivo Continuous Renal Replacement Therapy.

Biagi M, Butler D, Tan X, Qasmieh S, Tejani K, Patel S, Rivosecchi RM, Nguyen MH, Clancy CJ, Shields RK, Wenzler E.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01085-19. doi: 10.1128/AAC.01085-19. [Epub ahead of print]

PMID:
31527035
13.

Combating resistance while maintaining innovation: the future of antimicrobial stewardship.

Vickers RJ, Bassetti M, Clancy CJ, Garey KW, Greenberg DE, Nguyen MH, Roblin D, Tillotson GS, Wilcox MH.

Future Microbiol. 2019 Oct;14:1331-1341. doi: 10.2217/fmb-2019-0227. Epub 2019 Sep 17.

14.

Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model.

Drusano GL, Shields RK, Mtchedlidze N, Nguyen MH, Clancy CJ, Vicciarelli M, Louie A.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00462-19. doi: 10.1128/AAC.00462-19. Print 2019 Aug.

15.

Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study.

Nguyen MH, Clancy CJ, Pasculle AW, Pappas PG, Alangaden G, Pankey GA, Schmitt BH, Rasool A, Weinstein MP, Widen R, Hernandez DR, Wolk DM, Walsh TJ, Perfect JR, Wilson MN, Mylonakis E.

Ann Intern Med. 2019 Jun 18;170(12):845-852. doi: 10.7326/M18-2772. Epub 2019 May 14.

PMID:
31083728
16.

Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae.

Wilson WR, Kline EG, Jones CE, Morder KT, Mettus RT, Doi Y, Nguyen MH, Clancy CJ, Shields RK.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02048-18. doi: 10.1128/AAC.02048-18. Print 2019 Mar.

17.

Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms.

Wenzler E, Lee M, Wu TJ, Meyer KA, Shields RK, Nguyen MH, Clancy CJ, Humphries RM, Harrington AT.

J Antimicrob Chemother. 2019 Mar 1;74(3):633-638. doi: 10.1093/jac/dky483.

18.

Spontaneous Mutational Frequency and FKS Mutation Rates Vary by Echinocandin Agent against Candida glabrata.

Shields RK, Kline EG, Healey KR, Kordalewska M, Perlin DS, Nguyen MH, Clancy CJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01692-18. doi: 10.1128/AAC.01692-18. Print 2019 Jan.

19.

Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative.

Clancy CJ, Nguyen MH.

Diagn Microbiol Infect Dis. 2019 Jan;93(1):54-57. doi: 10.1016/j.diagmicrobio.2018.03.017. Epub 2018 Apr 6.

PMID:
30316561
20.

How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers.

Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen MH.

Clin Infect Dis. 2019 Feb 15;68(5):850-853. doi: 10.1093/cid/ciy669.

21.

Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Wu X, Clancy CJ, Rivosecchi RM, Zhao W, Shields RK, Marini RV, Venkataramanan R, Nguyen MH.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01643-18. doi: 10.1128/AAC.01643-18. Print 2018 Dec.

22.

Prevalence of Inappropriate Antibiotic Prescribing in Primary Care Clinics within a Veterans Affairs Health Care System.

Shively NR, Buehrle DJ, Clancy CJ, Decker BK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00337-18. doi: 10.1128/AAC.00337-18. Print 2018 Aug.

23.

Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam Resistance.

Shields RK, Nguyen MH, Hao B, Kline EG, Clancy CJ.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e01018-18. doi: 10.1128/AAC.01018-18. Print 2018 Aug.

24.

T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward.

Clancy CJ, Nguyen MH.

J Antimicrob Chemother. 2018 Mar 1;73(suppl_4):iv2-iv5. doi: 10.1093/jac/dky050.

PMID:
29608754
25.

Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections.

Shields RK, Nguyen MH, Chen L, Press EG, Kreiswirth BN, Clancy CJ.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02497-17. doi: 10.1128/AAC.02497-17. Print 2018 May.

26.

Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences.

Clancy CJ, Nguyen MH.

J Fungi (Basel). 2018 Feb 19;4(1). pii: E27. doi: 10.3390/jof4010027. Review.

27.

Diagnosing Invasive Candidiasis.

Clancy CJ, Nguyen MH.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01909-17. doi: 10.1128/JCM.01909-17. Print 2018 May. Review.

28.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475
29.

Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.

Mylonakis E, Zacharioudakis IM, Clancy CJ, Nguyen MH, Pappas PG.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01756-17. doi: 10.1128/JCM.01756-17. Print 2018 Apr.

30.

Water Cultures Are More Sensitive Than Swab Cultures for the Detection of Environmental Legionella.

Decker BK, Harris PL, Toy DL, Muder RR, Sonel AF, Clancy CJ.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):108-110. doi: 10.1017/ice.2017.235. Epub 2017 Nov 27.

PMID:
29173230
31.

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e01093-17. doi: 10.1128/JCM.01093-17. Print 2018 Feb.

32.

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.

Haidar G, Philips NJ, Shields RK, Snyder D, Cheng S, Potoski BA, Doi Y, Hao B, Press EG, Cooper VS, Clancy CJ, Nguyen MH.

Clin Infect Dis. 2017 Jul 1;65(1):110-120. doi: 10.1093/cid/cix182.

33.

Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model.

Zhao Y, Prideaux B, Nagasaki Y, Lee MH, Chen PY, Blanc L, Ho H, Clancy CJ, Nguyen MH, Dartois V, Perlin DS.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01009-17. doi: 10.1128/AAC.01009-17. Print 2017 Oct.

34.

Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature.

Shields RK, Nguyen MH, Press EG, Chen L, Kreiswirth BN, Clancy CJ.

Open Forum Infect Dis. 2017 Jul 1;4(3):ofx101. doi: 10.1093/ofid/ofx101. eCollection 2017 Summer.

35.

Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients.

Rivosecchi RM, Clancy CJ, Shields RK, Ensor CR, Shullo MA, Falcione BA, Venkataramanan R, Nguyen MH.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00970-17. doi: 10.1128/AAC.00970-17. Print 2017 Sep.

36.

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae.

Haidar G, Clancy CJ, Chen L, Samanta P, Shields RK, Kreiswirth BN, Nguyen MH.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00642-17. doi: 10.1128/AAC.00642-17. Print 2017 Sep.

37.

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.

Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, Doi Y, Kreiswirth BN, Clancy CJ.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00883-17. doi: 10.1128/AAC.00883-17. Print 2017 Aug.

38.

Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D; Gram-Negative Committee of the Antibacterial Resistance Leadership Group (ARLG)a.

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S30-S35. doi: 10.1093/cid/ciw829. Review.

39.

In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases.

Shields RK, Nguyen MH, Press EG, Chen L, Kreiswirth BN, Clancy CJ.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e00079-17. doi: 10.1128/AAC.00079-17. Print 2017 May.

40.

Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases.

Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MH.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02534-16. doi: 10.1128/AAC.02534-16. Print 2017 May.

41.

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.

Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16. doi: 10.1128/AAC.02097-16. Print 2017 Mar.

42.

Emergence of Candida auris: An International Call to Arms.

Clancy CJ, Nguyen MH.

Clin Infect Dis. 2017 Jan 15;64(2):141-143. doi: 10.1093/cid/ciw696. Epub 2016 Oct 20. No abstract available.

PMID:
27989986
43.

Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure.

Buehrle DJ, Shields RK, Clarke LG, Potoski BA, Clancy CJ, Nguyen MH.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01243-16. doi: 10.1128/AAC.01243-16. Print 2017 Jan.

44.

Candida albicans Transcriptional Profiling Within Biliary Fluid From a Patient With Cholangitis, Before and After Antifungal Treatment and Surgical Drainage.

Clancy CJ, Meslin C, Badrane H, Cheng S, Losada LC, Nierman WC, Vergidis P, Clark NL, Nguyen MH.

Open Forum Infect Dis. 2016 Jun 11;3(3):ofw120. eCollection 2016 Sep.

45.

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections.

Shields RK, Potoski BA, Haidar G, Hao B, Doi Y, Chen L, Press EG, Kreiswirth BN, Clancy CJ, Nguyen MH.

Clin Infect Dis. 2016 Dec 15;63(12):1615-1618. Epub 2016 Sep 13.

46.

Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.

Zhao Y, Nagasaki Y, Kordalewska M, Press EG, Shields RK, Nguyen MH, Clancy CJ, Perlin DS.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6573-6577. doi: 10.1128/AAC.01574-16. Print 2016 Nov.

47.

Surgical Site Infections After Liver Transplantation: Emergence of Multidrug-Resistant Bacteria and Implications for Prophylaxis and Treatment Strategies.

Viehman JA, Clancy CJ, Clarke L, Shields RK, Silveira FP, Kwak EJ, Vergidis P, Hughes C, Humar A, Nguyen MH.

Transplantation. 2016 Oct;100(10):2107-14. doi: 10.1097/TP.0000000000001356.

PMID:
27479167
48.

Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M.

Infect Immun. 2016 Sep 19;84(10):2724-39. doi: 10.1128/IAI.00469-16. Print 2016 Oct. Review.

49.

Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.

Haidar G, Alkroud A, Cheng S, Churilla TM, Churilla BM, Shields RK, Doi Y, Clancy CJ, Nguyen MH.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5208-14. doi: 10.1128/AAC.00869-16. Print 2016 Sep.

50.

Improving the Diagnosis of Legionella Pneumonia within a Healthcare System through a Systematic Consultation and Testing Program.

Decker BK, Harris PL, Muder RR, Hong JH, Singh N, Sonel AF, Clancy CJ.

Ann Am Thorac Soc. 2016 Aug;13(8):1289-93. doi: 10.1513/AnnalsATS.201510-715BC.

PMID:
27243279

Supplemental Content

Loading ...
Support Center